Keywords: Sanofi, Regeneron Pharma, Zaltrap, Colorectal cancer, USA, FDA

Zaltrap gains US approval for metastatic colorectal cancer

Article | 06 August 2012

Print This

The US Food and Drug Administration on Friday approved French drug major Sanofi (Euronext: SAN) and US partner Regeneron Pharmaceuticals& ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in